Identification of RBPMS as a smooth muscle master splicing regulator via association of its gene with super-enhancers
View / Open Files
Authors
Advisors
Smith, Christopher W J
Date
2020-02-22Awarding Institution
University of Cambridge
Author Affiliation
Biochemistry
Qualification
Doctor of Philosophy (PhD)
Language
English
Type
Thesis
Metadata
Show full item recordCitation
Nakagaki Silva, E. E. (2020). Identification of RBPMS as a smooth muscle master splicing regulator via association of its gene with super-enhancers (Doctoral thesis). https://doi.org/10.17863/CAM.44730
Abstract
Alternative splicing (AS) is primarily regulated by regulatory RNA-binding proteins (RBPs). It has been suggested that a small number of master splicing regulators might control cell-specific programs and these regulators could be identified via the association of their genes with transcriptional super-enhancers. Using this approach, RNA Binding Protein with Multiple Splicing (RBPMS) was identified as a critical splicing regulator in vascular smooth-muscle cells (SMCs). RBPMS is strongly downregulated during SMC dedifferentiation and is responsible for nearly 20% of the AS changes during this transition as indicated by mRNA-Seq of rat PAC1 cells with RBPMS-manipulated levels. RBPMS overexpression also promoted splicing events that are usually only observed in tissue SMCs. RBPMS targeted a network of proteins involved in the cytoskeleton and cell-adhesions, machineries remodelled during the transition from contractile to motile-dedifferentiated SMCs. RBPMS directly regulated target exons with a positional bias depending upon whether acting as an activator or repressor, as indicated by RBPMS-maps, in vivo transfections with minigene reporters, RBPMS
RNA binding mutant, MS2 artificial tethering and lastly in vitro binding assays. RBPMS controlled splicing and activity of other splicing and post-transcriptional regulators (MBNL1, MBNL2 and LSM14B) as well as the key SMC transcription factor Myocardin. Structure-function analyses revealed that the two major RBPMS isoforms (RBPMS-A and B) have differential activity, and that dimerization and RBPMS C- terminus are essential to RBPMS splicing activity. Yet, RBPMS RRM was insufficient for splicing. In fact, a core section of the C-terminus of RBPMS-B antagonized its repressor-splicing activity. Additionally, two threonine residues of RBPMS could be phosphorylated differentially modulating RBPMS isoforms activity. Therefore, this study provides the strongest evidence to date for a molecular function of RBPMS as a splicing-regulator, matching many of the expected criteria of a master regulator of AS in differentiated VSMCs.
Keywords
RBPMS, Vascular smooth muscle cells, Alternative splicing, PAC1 cells
Sponsorship
British Heart Foundation (BHF) PG/16/28/32123); Wellcome 092900/Z/10/Z and 209368/Z/17/Z; MCTI | Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) 206813/2014-7
Identifiers
This record's DOI: https://doi.org/10.17863/CAM.44730
Rights
All rights reserved